Shotwise
Wegovy, Ozempic, Mounjaro
Take control of your GLP-1 treatment journey with Shotwise, the ultimate companion app designed to simplify injection tracking and monitor your progress effortlessly. Shotwise helps you stay consistent, informed, and motivated.
Worldwide Release Date: January 9, 2025
Star Ratings(129 ratings | avg ★ 4.6)
App Store (129 ratings)
Last 28 days
Revenue
$2,519
AR
$30,228
MRR
$1,924
ARR
$23,088
Cash Flow Index
1.3x
Active Subscriptions
1,353
Active Trials
3
ARPAS
$1.86
Paid Subscriber Share (snapshot)
99.8%
Active Customers
788
New Customers
141
Subscription Penetration
171.7%
ARPU
$3.20
RPD
$3.20
ARPPU
$1.42
LTV
$5
MRR Growth (28d)
-27.1%
Revenue Growth (28d)
+82.2%
Subscriber Growth (28d)
-29.2%
All data is verified through RevenueCat. Last updated: Mar 9, 2026, 10:31:12 AM UTC.
App Screenshots
In-App Pricing
Tech Stack
About This Listing
A GLP-1 shot tracker app, low maintenance, huge market and potential for improvement. Also potential for expanded revenue through GLP-1 affiliates that is a huge opportunity but one I haven’t had the time or bandwidth to explore.
Asking Price
$38,480
Sale Details
Business Operations Started
Jan 2025
Assets Included in Sale
Source Code Included
Post-Sales Support
More apps for sale
Browse Marketplace ↗
Brainrot.mov
FOR SALELast 30 days rev
$9,645
MRR
$9,612
FitCal
FOR SALELast 30 days rev
$8,888
MRR
$7,476
-strive
FOR SALELast 30 days rev
$6,974
MRR
$10,486
Overlo
FOR SALELast 30 days rev
$1,594
MRR
$2,111
Push Up Time - App Blocker
FOR SALELast 30 days rev
$702
MRR
$746
CalBuddy
Last 30 days rev
$60,857
MRR
$22,477



